Rational approach to discover multipotent anti-Alzheimer drugs

被引：232
作者：
Rosini, M
Andrisano, V
Bartolini, M
Bolognesi, ML
Hrelia, P
Minarini, A
Tarozzi, A
Melchiorre, C
机构：
[1] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy
[2] Univ Bologna, Dept Pharmacol, I-40126 Bologna, Italy
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2005年 / 48卷 / 02期
关键词：
D O I：
10.1021/jm049112h
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The coupling of two different pharmacophores, each endowed with different biological properties, afforded the hybrid compound lipocrine (7), whose biological profile was markedly improved relative to those of prototypes tacrine and lipoic acid. Lipocrine is the first compound that inhibits the catalytic activity of AChE and AChE-induced amyloid-beta aggregation and protects against reactive oxygen species. Thus, it emerged as a valuable pharmacological tool to investigate Alzheimer's disease and as a promising lead compound for new anti-Alzheimer drugs.
引用
收藏
页码：360 / 363
页数：4
相关论文
共 22 条
  • [1] β-amyloid aggregation induced by human acetylcholinesterase:: inhibition studies
    Bartolini, M
    Bertucci, C
    Cavrini, V
    Andrisano, V
    [J]. BIOCHEMICAL PHARMACOLOGY, 2003, 65 (03) : 407 - 416
  • [2] On neurodegenerative diseases, models, and treatment strategies: Lessons learned and lessons forgotten a generation following the cholinergic hypothesis
    Bartus, RT
    [J]. EXPERIMENTAL NEUROLOGY, 2000, 163 (02) : 495 - 529
  • [3] The pharmacology of the antioxidant lipoic acid
    Biewenga, GP
    Haenen, GRMM
    Bast, A
    [J]. GENERAL PHARMACOLOGY, 1997, 29 (03): : 315 - 331
  • [4] BRYSON HM, 1997, DRUGS AGING, V10, P240
  • [5] Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice
    Capsoni, S
    Ugolini, G
    Comparini, A
    Ruberti, F
    Berardi, N
    Cattaneo, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (12) : 6826 - 6831
  • [6] TACRINE
    DAVIS, KL
    POWCHIK, P
    [J]. LANCET, 1995, 345 (8950) : 625 - 630
  • [7] ELLMAN GB, 1961, BIOCHEM PHARMACOL, V77, P88
  • [8] Rivastigmine: an update on therapeutic efficacy in Alzheimer's disease and other conditions
    Gabelli, C
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2003, 19 (02) : 69 - 82
  • [9] Alpha-lipoic acid as a new treatment option for Azheimer type dementia
    Hager, K
    Marahrens, A
    Kenklies, M
    Riederer, P
    Münch, G
    [J]. ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2001, 32 (03) : 275 - 282
  • [10] Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
    Hardy, J
    Selkoe, DJ
    [J]. SCIENCE, 2002, 297 (5580) : 353 - 356
123